Atlas Trials

Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5

Clinical trial NCT02392208 · COMPLETED

Trial details

NCT number
NCT02392208
Sponsor
University of Michigan
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
End-Stage Renal DiseaseStage 5 Chronic Kidney Disease
Start date
2015-07-01
Primary completion
2016-03-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.